Post-market Safety Reassessment of Ulinastatin for Injection

Clinical trial NCT02520570 · UNKNOWN

Trial details

NCT number: NCT02520570
Sponsor: Techpool Bio-Pharma Co., Ltd.
Status: UNKNOWN
Study type: OBSERVATIONAL

Adverse Reaction to Drug

Start date: 2014-08-01
Primary completion: 2018-06-01
Enrollment: 10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.